Search Results

There are 17681 results for: content related to: Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study

  1. Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 10, October 2013, Pages: 938–953, M. Monami, S. Genovese and E. Mannucci

    Version of Record online : 13 MAY 2013, DOI: 10.1111/dom.12116

  2. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis

    Diabetic Medicine

    Volume 29, Issue 8, August 2012, Pages: 1029–1035, K. M. Pantalone, M. W. Kattan, C. Yu, B. J. Wells, S. Arrigain, B. Nutter, A. Jain, A. Atreja and R. S. Zimmerman

    Version of Record online : 15 JUL 2012, DOI: 10.1111/j.1464-5491.2012.03577.x

  3. Metformin in Noninsulin-Dependent Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 16, Issue 3, May-June 1996, Pages: 327–351, Audrey Jade Lee

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1996.tb02964.x

  4. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Version of Record online : 17 APR 2013, DOI: 10.1002/pds.3432

  5. Type 2 Diabetes in Adults

    Staged Diabetes Management, 3rd Edition

    Roger S. Mazze, Ellie S. Strock, Richard M. Bergenstal, Amy Criego, Robert Cuddihy, Oded Langer, Gregg D. Simonson, Margaret A. Powers, Pages: 77–137, 2011

    Published Online : 3 NOV 2011, DOI: 10.1002/9781119950424.ch5

  6. CARDIOVASCULAR EFFECTS OF ORAL HYPOGLYCAEMIC DRUGS

    Clinical and Experimental Pharmacology and Physiology

    Volume 23, Issue 3, March 1996, Pages: 201–206, Laurence Guy Howes, Purnima Sundaresan and Denise Lykos

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-1681.1996.tb02596.x

  7. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 9, September 2012, Pages: 803–809, K. M. Pantalone, M. W. Kattan, C. Yu, B. J. Wells, S. Arrigain, A. Jain, A. Atreja and R. S. Zimmerman

    Version of Record online : 29 APR 2012, DOI: 10.1111/j.1463-1326.2012.01604.x

  8. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus

    Diabetes/Metabolism Research and Reviews

    Volume 31, Issue 6, September 2015, Pages: 619–626, Chin-Hsiao Tseng

    Version of Record online : 13 MAY 2015, DOI: 10.1002/dmrr.2649

  9. Sulfonylurea Treatment of Type 2 Diabetes Mellitus: Focus on Glimepiride

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 5, May 2004, Pages: 606–620, Mary T. Korytkowski

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.6.606.34752

  10. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 1, January 2012, Pages: 23–29, S. Bo, G. Ciccone, R. Rosato, P. Villois, G. Appendino, E. Ghigo and G. Grassi

    Version of Record online : 21 NOV 2011, DOI: 10.1111/j.1463-1326.2011.01480.x

  11. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 9, September 2012, Pages: 810–820, S.-C. Liu, Y.-K. Tu, M.-N. Chien and K.-L. Chien

    Version of Record online : 29 APR 2012, DOI: 10.1111/j.1463-1326.2012.01606.x

  12. Metformin, a Promising Oral Antihyperglycemic for the Treatment of Noninsulin-Dependent Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 1, January-February 1997, Pages: 62–73, Elena M. Wildasin, Debra J. Skaar, William R. Kirchain and Michelle Hulse

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03678.x

  13. Assessment of effects on non-target plants from sulfonylurea herbicides using field approaches

    Pesticide Science

    Volume 52, Issue 3, March 1998, Pages: 199–217, Timothy T. Obrigawitch, Gilbert Cook and Jeff Wetherington

    Version of Record online : 26 MAR 1999, DOI: 10.1002/(SICI)1096-9063(199803)52:3<199::AID-PS696>3.0.CO;2-Y

  14. Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 1, January 2010, Pages: 52–56, K Zhou, L Donnelly, L Burch, R Tavendale, A S F Doney, G Leese, A T Hattersley, M I McCarthy, A D Morris, C C Lang, C N A Palmer and E R Pearson

    Version of Record online : 30 SEP 2009, DOI: 10.1038/clpt.2009.176

  15. Glyburide: A Second-generation Sulfonylurea Hypoglycemic Agent

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 5, Issue 2, March-April 1985, Pages: 43–62, Jerome M. Feldman

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1985.tb03404.x

  16. Sulfonylureas: Basic Aspects and Clinical Uses

    Standard Article

    International Textbook of Diabetes Mellitus

    H.E. Lebovitz and A. Melander

    Published Online : 15 MAR 2004, DOI: 10.1002/0470862092.d0608

  17. Combine and conquer: advantages and disadvantages of fixed-dose combination therapy

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 4, April 2013, Pages: 291–300, D. S. H. Bell

    Version of Record online : 25 OCT 2012, DOI: 10.1111/dom.12015

  18. You have free access to this content
    Comparing the actions of older and newer therapies on body weight: to what extent should these effects guide the selection of antidiabetic therapy?

    International Journal of Clinical Practice

    Volume 64, Issue 6, May 2010, Pages: 791–801, I. W. Campbell

    Version of Record online : 9 APR 2010, DOI: 10.1111/j.1742-1241.2009.02292.x

  19. Combination Use of Sulfonylureas and Insulin in the Treatment of Noninsulin-Dependent Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 12, Issue 4, July-August 1992, Pages: 292–299, Patricia A. Montgomery

    Version of Record online : 24 FEB 2012, DOI: 10.1002/j.1875-9114.1992.tb04463.x

  20. Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 6, June 2015, Pages: 567–575, Hsien-Yen Chang, Chi-Feng Hsieh, Sonal Singh, Wenze Tang, Yi-Ting Chiang and Weng-Foung Huang

    Version of Record online : 7 APR 2015, DOI: 10.1002/pds.3770